Find weekly COMPPARE activation and enrollment updates here.
The following meters are reported as of 6/30/20:
- The COMPPARE Consortium has activated 100% of the 45 partner sites that will enroll patients.
- Patient Enrollment. The COMPPARE study will enroll 1500 patients receiving photon therapy and 1500 patients receiving proton therapy. As of 6/30/20, COMPPARE has enrolled 669 participants, or 22% of goal.
- Current Enrollment Breakdown The current RCT, current photon, and current pragmatic proton enrollments. As of 6/30/30, COMPPARE has enrolled 120 photon participants, 175 RCT proton participants, and 374 pragmatic proton participants.